Univariate analysis showed that HCC patients with low RASSF10 expression had shorter overall survival (OS) and disease-free survival (DFS) after curative resection than those with high RASSF10 expression (Figure 1D-1E). This evidence concerns the gene RASSF10 and hepatocellular carcinoma.